Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors
(NASDAQ:JSPR), LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Jasper Therapeutics, Inc., (“Jasper” or the “Company”) (NASDAQ: JSPR) investors of a class action on behalf of investors that bought securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”). Jasper investors have until November 18, 2025 to […]